NUPLAZID Trademark

Trademark Overview

On Tuesday, January 26, 2016, a trademark application was filed for NUPLAZID with the United States Patent and Trademark Office. The USPTO has given the NUPLAZID trademark a serial number of 86886134. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 4, 2023. This trademark is owned by ACADIA Pharmaceuticals Inc.. The NUPLAZID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
nuplazid

General Information

Serial Number86886134
Word MarkNUPLAZID
Filing DateTuesday, January 26, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 4, 2023
Registration Number5097134
Registration DateTuesday, December 6, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "NUPLAZID" in stylized letters with a triangle forming the dot over the letter "I".
Goods and ServicesPharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 29, 2016
Primary Code005
First Use Anywhere DateTuesday, May 31, 2016
First Use In Commerce DateTuesday, May 31, 2016

Trademark Owner History

Party NameACADIA Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameACADIA Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameACADIA Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Friday, January 29, 2016NEW APPLICATION ENTERED
Friday, January 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 30, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 11, 2016ASSIGNED TO EXAMINER
Thursday, May 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, October 11, 2016USE AMENDMENT FILED
Thursday, October 27, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 1, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 1, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 2, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 6, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, April 4, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 23, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 4, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 4, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

nuplazid psychologic psychiatric diseases disorders genetic metabolic preparations prevention treatment neurologic